WEC
GILD icon

Winslow Evans & Crocker’s Gilead Sciences GILD Stock Holding History

Winslow Evans & Crocker’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$807K Buy
13,855
+432
+3% +$26.1K 0.15% 149
2020
Q3 		$848K Sell
13,423
-449
-3% -$31.1K 0.21% 110
2020
Q2 		$1.07M Sell
13,872
-1,054
-7% -$80.8K 0.28% 79
2020
Q1 		$1.12M Sell
14,926
-876
-6% -$60.5K 0.37% 65
2019
Q4 		$1.03M Buy
15,802
+82
+0.5% +$5.34K 0.26% 88
2019
Q3 		$998K Sell
15,720
-470
-3% -$30.7K 0.28% 85
2019
Q2 		$1.1M Sell
16,190
-424
-3% -$27.9K 0.31% 74
2019
Q1 		$1.08M Sell
16,614
-164
-1% -$10.9K 0.31% 77
2018
Q4 		$1.05M Sell
16,778
-4,374
-21% -$306K 0.35% 65
2018
Q3 		$1.63M Sell
21,152
-726
-3% -$54.8K 0.5% 46
2018
Q2 		$1.55M Sell
21,878
-598
-3% -$42.2K 0.49% 48
2018
Q1 		$1.69M Buy
22,476
+42
+0.2% +$3.34K 0.55% 44
2017
Q4 		$1.61M Sell
22,434
-8,978
-29% -$682K 0.52% 47
2017
Q3 		$2.54M Sell
31,412
-3,013
-9% -$230K 0.84% 26
2017
Q2 		$2.43M Sell
34,425
-855
-2% -$56.9K 0.67% 32
2017
Q1 		$2.4M Sell
35,280
-3,778
-10% -$266K 0.75% 28
2016
Q4 		$2.8M Sell
39,058
-5,992
-13% -$445K 0.86% 26
2016
Q3 		$3.56M Sell
45,050
-2,882
-6% -$234K 1.02% 21
2016
Q2 		$4M Sell
47,932
-2,336
-5% -$207K 1.19% 16
2016
Q1 		$4.62M Sell
50,268
-670
-1% -$60.4K 1.39% 11
2015
Q4 		$5.15M Sell
50,938
-990
-2% -$103K 1.48% 9
2015
Q3 		$5.1M Buy
51,928
+7,372
+17% +$819K 1.6% 10
2015
Q2 		$5.22M Buy
44,556
+2,034
+5% +$222K 1.47% 9
2015
Q1 		$4.17M Sell
42,522
-1,244
-3% -$126K 1.18% 14
2014
Q4 		$4.13M Sell
43,766
-7,274
-14% -$752K 1.18% 14
2014
Q3 		$5.43M Buy
51,040
+43,669
+592% +$4.28M 1.56% 7
2014
Q2 		$611K Hold
7,371
– – 0.2% 122
2014
Q1 		$522K Buy
7,371
+10
+0.1% +$784 0.18% 136
2013
Q4 		$553K Buy
+7,361
New +$513K 0.19% 134

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Winslow Evans & Crocker's GILD Position: Q4 2020 in Review

Winslow Evans & Crocker increased its Gilead Sciences (GILD) stake by 3.2% in Q4 2020, buying an estimated $26.1K and bringing the position to 13,855 shares worth $807K. The position accounts for 0.15% of the portfolio, ranked #149.

Winslow Evans & Crocker first reported a position in GILD in Q4 2013 and has held it in 29 quarters since. The position peaked at $5.43M in Q3 2014. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • Winslow Evans & Crocker held 13,855 shares of Gilead Sciences worth $807K as of Q4 2020.
  • Winslow Evans & Crocker bought 432 Gilead Sciences shares in Q4 2020, an estimated $26.1K.
  • Gilead Sciences made up 0.15% of Winslow Evans & Crocker's portfolio in Q4 2020, its #149 holding.
  • Winslow Evans & Crocker first reported a position in Gilead Sciences in Q4 2013 and has held it in 29 quarters since.
  • Winslow Evans & Crocker's Gilead Sciences position peaked at $5.43M in Q3 2014.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.